HtrA Serine Peptidase 4 (HTRA4) (Middle Region) Peptide
-
- Target See all HTRA4 products
- HTRA4 (HtrA Serine Peptidase 4 (HTRA4))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-HTRA4 antibody (Catalog #: ARP55603_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- HTRA4 (HtrA Serine Peptidase 4 (HTRA4))
- Synonyms
- B430206E18Rik Peptide, RGD1306242 Peptide, HtrA serine peptidase 4 Peptide, HTRA4 Peptide, Htra4 Peptide
- Background
-
HTRA4 is a member of the HtrA family of proteases. The protein contains a putative signal peptide, an insulin growth factor binding domain, a Kazal protease inhibitor domain, a conserved trypsin domain and a PDZ domain. Based on studies on other related family members, this enzyme may function as a secreted oligomeric chaperone protease to degrade misfolded secretory proteins. Other human HtrA proteins have been implicated in arthritis, tumor suppression, unfolded stress response, apoptosis, and aging.
Alias Symbols: FLJ90724
Protein Size: 476 - Molecular Weight
- 51 kDa
- Gene ID
- 203100
- NCBI Accession
- NM_153692, NP_710159
- UniProt
- P83105
-